BioNTech has more cancer drugs in late-stage trials than most investors realize. Is it a buy under $100?

BioNTech's cancer pipeline is bigger than its COVID-era reputation suggests, and the stock still trades below $100.

The U.S. Government Wants To Speed Up Clinical Trials. What Will That Mean For New Drugs?

The U.S. Department of Health and Human Services (HHS) launched a new initiative to accelerate clinical trials on September ...
RTTNews

Phase 1, 2, And 3 Clinical Trials Explained: What Every Biotech Investor Needs To Know

Clinical trials are a key driver of biotech stocks. Every new therapy must pass through a series of testing, Phase 1, Phase 2 ...

VivoSim: Conducting Early Clinical Trials With Lab-Grown Human Tissue

VivoSim is a San Diego biotech company whose goal is to limit the impact of failure in human trials. By using lab-grown human ...
CNN

You want to join a clinical trial. Here’s what to know about the hurdles.

Connecting people with clinical trials is complicated — even if people identify a promising match, there’s a slew of potentially thorny factors, including geographic incompatibility, and financial and ...

ClinPro Trials™ Launches Independent Clinical Compliance Assessment for Trials Still in Progress

The Compliance CRO™, today announced its independent clinical compliance assessment service for biopharmaceutical sponsors, boards, and investors.
Targeted Oncology

Dr Premji on Community Trials and the Evolving Breast Cancer Landscape

Broader community enrollment improves external validity by capturing patients with comorbidities and real-world treatment patterns, while familiarizing clinicians with toxicity management before ...
Fierce Biotech

ARPA-H unveils Surpass program to accelerate and expand clinical trials

The U.S. Department of Health and Human Services announced the launching of a new program aimed to remove barriers that slow clinical development and transform how clinical trials are designed and ...